FDA NDC Directory · JSON-LD · Markdown

Sucralfate

NDC 65162-062 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameSucralfate Oral
Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA209356
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSUCRALFATE (1 g/10mL)
Marketing started20191202
Package count2

External sources

Source: openFDA. Public-domain (CC0).